文献速递艾滋病与性传播感染结核与非结核分枝杆菌

非洲晚期HIV住院成人经验性抗结核治疗:将治疗阈值应用于临床实践

Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice.
PubMed 文献 · Lancet Infect Dis · 2026-07-27

在撒哈拉以南非洲,晚期HIV住院成人死亡率高,结核常为播散性且未确诊。尽管延误抗结核治疗与死亡率增加相关,经验性治疗可能改善高危患者生存。本文应用治疗阈值框架,论证对重症晚期HIV住院患者应更早启动经验性抗结核治疗,同时进行诊断评估和结构化再评估。

要点

  • 晚期HIV住院成人结核预检概率高,常超过治疗获益大于风险的治疗阈值。
  • 即使短期延误抗结核治疗也与死亡率显著增加相关。
  • 短期经验性抗结核治疗看似安全,毒性、药物相互作用和过度治疗风险可能被未治疗疾病的后果抵消。

核心结论

  • 对重症晚期HIV住院成人,经验性抗结核治疗可能改善生存,应转向更早经验性治疗。

研究设计与样本

  • 本文为基于近期试验和队列研究证据的论述性文章,应用治疗阈值框架分析临床实践。

主要发现

  • 近期试验和队列研究提示,即使短期延误抗结核治疗也与死亡率显著增加相关。
  • 经验性治疗可能改善高危人群的生存。
  • 重症晚期HIV住院患者的结核预检概率常超过治疗获益大于风险的治疗阈值。

临床怎么用

  • 对选定的重症晚期HIV住院患者,应更早启动经验性抗结核治疗,并平行进行诊断评估和结构化再评估。

局限性

  • 需要足够样本量、以死亡率为终点的随机对照试验来验证经验性治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hospitalised adults with advanced HIV disease in sub-Saharan Africa experience high mortality, with tuberculosis, often disseminated and undiagnosed, being a leading cause. Despite this, initiation of antituberculous therapy is frequently delayed pending diagnostic confirmation, which may be unavailable in this population. Evidence from recent trials and cohort studies suggests that even short delays in antituberculous therapy are associated with substantial increases in mortality, whereas empiric therapy might improve survival in people at high risk. Applying the therapeutic threshold framework, the high pre-test probability of tuberculosis in severely ill inpatients with advanced HIV disease often exceeds the threshold at which treatment benefits outweigh risks, even in the absence of confirmatory testing. Although concerns regarding toxicity, drug interactions, and overtreatment are valid, short-term empiric antituberculous therapy appears safe and these risks might be outweighed by the consequences of untreated disease. We argue for a paradigm shift towards earlier empiric antituberculous therapy, with parallel diagnostic evaluation and structured reassessment in selected patients, and for adequately powered randomised controlled trials of empiric therapy powered for mortality.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Boyles T, Ellis J, Feasey N, et al. Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice. Lancet Infect Dis. 2026. PMID: 42508442. doi:10.1016/S1473-3099(26)00351-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。